ArticlePloS one2015

ALK kinase domain mutations in primary anaplastic large cell lymphoma: consequences on NPM-ALK activity and sensitivity to tyrosine kinase inhibitors.

Federica Lovisa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.